✦ LIBER ✦

The US Food and Drug Administration perspective on cancer biomarker development

✍ Scribed by Gutman, Steven; Kessler, Larry G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

When to Conduct a Renal Impairment Study

✍ Huang, S-M; Temple, R; Xiao, S; Zhang, L; Lesko, L J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 195 KB

Bone quality: A perspective from the foo

✍ Theresa Kehoe 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 77 KB

Environmental assessment of avermectins

✍ Raanan A. Bloom; John C. Matheson III 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 887 KB

How the US Food and Drug Administration

✍ Kathleen C Ellwood; Paula R Trumbo; Claudine J Kavanaugh 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Finding, evaluating, and managing drug-r

✍ Joyce Weaver; Lois La Grenade; Hyon Kwon; Mark Avigan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

US food and drug administration approval

✍ Richard D. Pearson; Selma M. B. Jeronimo; Susan M. Lareau 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 49 KB